38.5 D-
Epitalon
Also known as: Epithalon, Epithalone, Tetrapeptide-2
Emerging Research Category 2 Restricted
Research Evidence 12.0/100
Safety Profile 65.0/100
0 Clinical Trials
No clinical trials registered for this peptide.
19 Research Papers
- [Peptides and CCL11 and HMGB1 as molecular markers of aging: literature review and own data]. Adv Gerontol Review
- [The influence of AEDG and KE peptides on mitochondries stain and L7A ribosomes protein expression during human pineal gland and thymus cell senescence in vitro.]. Adv Gerontol unknown
- Short Exogenous Peptides Regulate Expression of CLE, KNOX1, and GRF Family Genes in Nicotiana tabacum. Biochemistry (Mosc) unknown
- Effects of Geroprotectors on Age-Related Changes in Proteolytic Digestive Enzyme Activities at Different Lighting Conditions. Bull Exp Biol Med unknown
- [Main mechanisms of rhabdomyolysis-caused kidney injury and their correction by organospecific peptides]. Biofizika unknown
Showing 5 of 19 papers by citation count.
FDA Data
Not FDA-Approved
Epitalon has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.
This peptide is classified as FDA Category 2 — it is prohibited from use in compounding pharmacies effective 2024. Obtaining it requires unregulated sources.
Frequently Asked Questions
Is Epitalon FDA approved?
No, Epitalon is not FDA approved. It is classified as FDA Category 2 and is banned from compounding pharmacies.
What is the trust score for Epitalon?
Epitalon has a CheckPeptides trust score of 38.5/100 (grade: D-). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026
Quick Facts
- Classification
- Tetrapeptide telomerase activator
- Molecular Weight
- 390.35 Da
- PubChem
- CID 219042 ↗
- Regulatory Status
- N/A
Score Breakdown
Research Evidence 12.0/100
Safety Profile 65.0/100
Evidence Summary
- Clinical Trials
- 0
- Research Papers
- 19
- Trust Score
- 38.5/100
- Grade
- D-